3671 - 3680 of 8715 Results
Title
Year
-
RESTRICTEDTitle: Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 491End Page: 501Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30108-3Citation Count: 129
-
RESTRICTEDTitle: Developing therapies for Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 10Start Page: 797End Page: 797Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3Best OA location URL: http://www.thelancet.com/article/S1474442220303203/pdfCitation Count: 5
-
RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1
-
RESTRICTEDTitle: Movement disorders in 2019: from antibodies to lifestyle interventionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 10End Page: 12Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133486Citation Count: 1
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1
-
OPENTitle: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6924570Citation Count: 1
-
OPENTitle: Provisional case definitions for COVID-19-associated neurological diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 890End Page: 891Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30373-2Best OA location URL: http://www.thelancet.com/article/S1474442220303732/pdfCitation Count: 7
-
RESTRICTEDTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 888End Page: 889Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30355-0Citation Count: 0
-
OPENTitle: Huntington's disease in BangladeshJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 644End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30216-7Best OA location URL: http://www.thelancet.com/article/S1474442220302167/pdfCitation Count: 1
-
OPENTitle: Long before Huntington's disease: what matters most?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 473End Page: 475Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30156-3Best OA location URL: http://www.thelancet.com/article/S1474442220301563/pdfCitation Count: 0